51. Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping.
- Author
-
Lou Q, Hansen BJ, Fedorenko O, Csepe TA, Kalyanasundaram A, Li N, Hage LT, Glukhov AV, Billman GE, Weiss R, Mohler PJ, Györke S, Biesiadecki BJ, Carnes CA, and Fedorov VV
- Subjects
- Action Potentials drug effects, Adenosine administration & dosage, Adenosine pharmacology, Adenosine toxicity, Adenosine A1 Receptor Antagonists pharmacology, Adenosine A1 Receptor Antagonists therapeutic use, Animals, Atrial Fibrillation etiology, Atrial Fibrillation physiopathology, Bradycardia etiology, Cardiac Pacing, Artificial adverse effects, Dogs, Dose-Response Relationship, Drug, Fibrosis, Heart Conduction System drug effects, Heart Conduction System physiopathology, Heart Failure genetics, Receptor, Adenosine A1 genetics, Receptor, Adenosine A1 physiology, Sinoatrial Node drug effects, Sinoatrial Node pathology, Tachycardia etiology, Theophylline pharmacology, Theophylline therapeutic use, Up-Regulation, Xanthines pharmacology, Xanthines therapeutic use, Bradycardia physiopathology, Heart Failure physiopathology, Receptor, Adenosine A1 biosynthesis, Sinoatrial Node physiopathology, Tachycardia physiopathology, Voltage-Sensitive Dye Imaging methods
- Abstract
Background: Although sinoatrial node (SAN) dysfunction is a hallmark of human heart failure (HF), the underlying mechanisms remain poorly understood. We aimed to examine the role of adenosine in SAN dysfunction and tachy-brady arrhythmias in chronic HF., Methods and Results: We applied multiple approaches to characterize SAN structure, SAN function, and adenosine A1 receptor expression in control (n=17) and 4-month tachypacing-induced chronic HF (n=18) dogs. Novel intramural optical mapping of coronary-perfused right atrial preparations revealed that adenosine (10 μmol/L) markedly prolonged postpacing SAN conduction time in HF by 206 ± 99 milliseconds (versus 66 ± 21 milliseconds in controls; P=0.02). Adenosine induced SAN intranodal conduction block or microreentry in 6 of 8 dogs with HF versus 0 of 7 controls (P=0.007). Adenosine-induced SAN conduction abnormalities and automaticity depression caused postpacing atrial pauses in HF versus control dogs (17.1 ± 28.9 versus 1.5 ± 1.3 seconds; P<0.001). Furthermore, 10 μmol/L adenosine shortened atrial repolarization and led to pacing-induced atrial fibrillation in 6 of 7 HF versus 0 of 7 control dogs (P=0.002). Adenosine-induced SAN dysfunction and atrial fibrillation were abolished or prevented by adenosine A1 receptor antagonists (50 μmol/L theophylline/1 μmol/L 8-cyclopentyl-1,3-dipropylxanthine). Adenosine A1 receptor protein expression was significantly upregulated during HF in the SAN (by 47 ± 19%) and surrounding atrial myocardium (by 90 ± 40%). Interstitial fibrosis was significantly increased within the SAN in HF versus control dogs (38 ± 4% versus 23 ± 4%; P<0.001)., Conclusions: In chronic HF, adenosine A1 receptor upregulation in SAN pacemaker and atrial cardiomyocytes may increase cardiac sensitivity to adenosine. This effect may exacerbate conduction abnormalities in the structurally impaired SAN, leading to SAN dysfunction, and potentiate atrial repolarization shortening, thereby facilitating atrial fibrillation. Atrial fibrillation may further depress SAN function and lead to tachy-brady arrhythmias in HF., (© 2014 American Heart Association, Inc.)
- Published
- 2014
- Full Text
- View/download PDF